Proton pump inhibitors and the risk of severe cognitive impairment: The role of posttraumatic stress disorder

Sean A.P. Clouston1, Oren Shapira2, Roman Kotov2, Lan Lei3, Monika Waszczuk2, Evelyn J. Bromet2, Benjamin J. Luft4
1Department of Family, Population, and Preventive Medicine and Program in Public Health, Stony Brook University, Stony Brook, NY
2Department of Psychiatry, Stony Brook University, Stony Brook, NY
3Division of Evaluative Science, Program in Public Health, Stony Brook University, Stony Brook, NY
4Department of Medicine, Stony Brook University, Stony Brook, NY

Tóm tắt

AbstractIntroductionProton pump inhibitors (PPIs), a common treatment for gastroesophageal reflux disease (GERD), were recently associated with increased risk of dementia. However, severe or chronic stress including, for example, posttraumatic stress disorder (PTSD) was not accounted for. This study examined whether PPI use was associated with severe cognitive impairment (SCI) and whether PTSD explained this association in a cohort of World Trade Center (WTC) responders.MethodA prospective cohort study of 3779 WTC responders attending a university‐based monitoring and treatment program. Prescriptions for PPIs and SCI determined using the Montreal Cognitive Assessment were the focus of the analysis.ResultsOverall, 1451 (38.4%) responders were dispensed PPIs, and 83 (2.2%) had SCI. Bivariable analyses revealed significant associations between being‐dispensed PPIs in relation to SCI. After adjusting for PTSD, major depressive disorder, WTC exposures, age, and sex, being‐dispensed PPIs were significantly associated with odds of SCI (adjusted odds ratio = 1.67 95% confidence interval = 1.054–2.643).ConclusionsBeing‐dispensed PPIs were associated with SCI in this analysis of WTC responders. Results suggest that clinicians treating GERD seek to both understand patients' mental health history and monitor cognitive functioning when designing treatment routines. Overall, results confirmed that this is an important area of investigation with potential direct clinical implications.

Tài liệu tham khảo

10.2165/00003088-200847010-00001 10.1007/s00406-014-0554-0 10.1001/jamaneurol.2015.4791 10.3164/jcbn.16-9 10.1097/PSY.0000000000000116 10.1016/j.dadm.2016.08.001 10.1001/archgenpsychiatry.2010.61 10.1016/j.jalz.2013.03.005 10.1038/ajg.2011.300 Dasaro C.R., 2015, Cohort Profile: World Trade Center Health Program General Responder Cohort, Int J Epidemiol, 46 10.1111/j.1532-5415.2005.53221.x 10.1002/gps.2101 10.1016/0005-7967(96)00033-2 10.1037/1040-3590.10.2.90 10.1016/S0140-6736(11)61180-X 10.1016/j.neurobiolaging.2003.12.023 10.1017/S0033291715002184 10.1017/S0033291717000708 10.1016/j.jpeds.2014.12.067 Brenner S.R., 2013, Blue‐green algae or cyanobacteria in the intestinal micro‐flora may produce neurotoxins such as Beta‐N‐Methylamino‐L‐Alanine (BMAA) which may be related to development of amyotrophic lateral sclerosis, Alzheimer's disease and Parkinson‐Dementia‐Complex in humans and Equine Motor Neuron Disease in horses, Med Hypotheses, 80, 103, 10.1016/j.mehy.2012.10.010